Replies to post #14363 on Celsion Corporation (CLSN)

[cameron12x]

I'm not sure if the stock is undervalued at this point.

The only thing propping up the stock price at the moment is "hope." Hope that something "magical" will happen in the next few months, based on existing P3 trial data. Well folks, that data has already been sliced and diced. There is nothing else to learn from it.

A new (confirmatory) trial will be needed (at least by the FDA), and the CEO mentioned that during the last conference call.

As for Hisun and the CFDA, that's the only real positive wildcard left out there. And it's a longshot at best whether TDOX can be commercialized based on a failed P3 trial in China.

The ONLY short-term hope for investors is if the subgroup cohort showing the best results actually came from Chinese patient. Remember, there were only (15) U.S. patients in the entire trial!